Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study investigates possible beneficial effects of peri-operative treatment (i.e.
pre-transplant initiation and prompt post-transplant continuation) with azithromycin in lung
transplantation. Our hypothesis is that this therapy will improve early allograft function
and outcome following human lung transplantation.
Phase:
Phase 4
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Collaborators:
Fund for Scientific Research, Flanders, Belgium Katholieke Universiteit Leuven KU Leuven